➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts
Harvard Business School

Last Updated: May 13, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Barusiban

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the drug development status for Barusiban?

Barusiban is an investigational drug.

There have been 4 clinical trials for Barusiban. The most recent clinical trial was a Phase 2 trial, which was initiated on March 1st 2016.

The most common disease conditions in clinical trials are Premature Birth, Obstetric Labor, Premature, and Infertility. The leading clinical trial sponsors are Ferring Pharmaceuticals, Tel-Aviv Sourasky Medical Center, and [disabled in preview].

There are thirty-one US patents protecting this investigational drug and two hundred and fifty-four international patents.

Recent Clinical Trials for Barusiban
Tocolytic Therapy for Preterm Labor in Multiple GestationTel-Aviv Sourasky Medical CenterPhase 3
Barusiban Subcutaneously for Reducing Implantation Failure Due to Uterine ContractionsFerring PharmaceuticalsPhase 2
Effect of Oxytocin Antagonist on Reduction of Uterine ContractionsFerring PharmaceuticalsPhase 2

See all Barusiban clinical trials

Clinical Trial Summary for Barusiban

Top disease conditions for Barusiban
Top clinical trial sponsors for Barusiban

See all Barusiban clinical trials

US Patents for Barusiban

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Barusiban   Get Started for $10 Permeant delivery system and methods for use thereof NITTO DENKO CORPORATION (Tokyo, JP)   Get Started for $10
Barusiban   Get Started for $10 Oxytocin receptor antagonist therapy in the luteal phase for implantation and pregnancy in women undergoing assisted reproductive technologies Ferring B.V. (Hoofddorp, NL)   Get Started for $10
Barusiban   Get Started for $10 Alpha-amino esters of hydroxypropylthiazolidine carboxamide derivative and salt form, crystal polymorph thereof Merck Serono S.A. (Coinsins, CH)   Get Started for $10
Barusiban   Get Started for $10 Controlled absorption water-soluble pharmaceutically active organic compound formulation for once-daily administration STI PHARMA, LLC (Newtown, PA)   Get Started for $10
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Barusiban

Drugname Country Document Number Estimated Expiration Related US Patent
Barusiban Australia AU2009231739 2028-03-31   Get Started for $10
Barusiban Canada CA2720067 2028-03-31   Get Started for $10
Barusiban Canada CA3084317 2028-03-31   Get Started for $10
Barusiban China CN102088935 2028-03-31   Get Started for $10
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim
Johnson and Johnson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.